Cargando…
Impact of amyloid β aggregate maturation on antibody treatment in APP23 mice
INTRODUCTION: The deposition of the amyloid β protein (Aβ) in the brain is a hallmark of Alzheimer's disease (AD). Removal of Aβ by Aβ-antibody treatment has been developed as a potential treatment strategy against AD. First clinical trials showed neither a stop nor a reduction of disease progr...
Autores principales: | Balakrishnan, Karthikeyan, Rijal Upadhaya, Ajeet, Steinmetz, Julia, Reichwald, Julia, Abramowski, Dorothee, Fändrich, Marcus, Kumar, Sathish, Yamaguchi, Haruyasu, Walter, Jochen, Staufenbiel, Matthias, Thal, Dietmar Rudolf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491274/ https://www.ncbi.nlm.nih.gov/pubmed/26141728 http://dx.doi.org/10.1186/s40478-015-0217-z |
Ejemplares similares
-
The type of Aβ-related neuronal degeneration differs between amyloid precursor protein (APP23) and amyloid β-peptide (APP48) transgenic mice
por: Rijal Upadhaya, Ajeet, et al.
Publicado: (2013) -
High-molecular weight Aβ oligomers and protofibrils are the predominant Aβ species in the native soluble protein fraction of the AD brain
por: Upadhaya, Ajeet Rijal, et al.
Publicado: (2012) -
Modified amyloid variants in pathological subgroups of β‐amyloidosis
por: Gerth, Janina, et al.
Publicado: (2018) -
Expression of complement system components during aging and amyloid deposition in APP transgenic mice
por: Reichwald, Julia, et al.
Publicado: (2009) -
Different aspects of Alzheimer’s disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia
por: Thal, Dietmar Rudolf, et al.
Publicado: (2019)